Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
2.91 Up 0.23(8.58%) Aug 31, 4:00PM EDT
Add to Portfolio
Prev Close:2.68
Open:2.68
Bid:1.46 x 200
Ask:3.33 x 100
1y Target Est:5.75
Beta:0.766367
Earnings Date:Oct 28 - Nov 2 (Est.)
Day's Range:2.67 - 3.22
52wk Range:1.38 - 4.10
Volume:1,896,747
Avg Vol (3m):895,068
Market Cap:86.69M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIUp 8.58%86.69M
BMYDown 1.88%99.17B
CELGDown 4.80%93.35B
PFEDown 1.35%198.71B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.90
Quarterly EPS Est (Sep-15) :-0.20
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback